MBK Partners to acquire Japan drugmaker Alinamin for $2.1 bil. – MBK Partners

Skip to content

Investor Relations

FIRM
Strategy
Team
Portfolio
News

Contact
Privacy notice
Terms of use

Portrait only

MBK Partners to acquire Japan drugmaker Alinamin for $2.1 bil.

July 9, 2024

Post navigation

List

Contact
Privacy notice
Terms of use

©2026 MBK Partners. All rights reserved.

This website uses cookies. By continuing, you agree to use of cookies, Learn more.

Investor Login

Forgot your password? Reset password

Problems accessing your account? webservice@mbkpartners.com

Are you sure you want to leave this page?

Stay on this Page Leave this Page

Register New Account

Problems accessing your account? webservice@mbkpartners.com

Reset Password

Problems accessing your account? webservice@mbkpartners.com